Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.

Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.

Sponsors

Lead Sponsor: Colgate Palmolive

Source Colgate Palmolive
Brief Summary

Clinical research study to determine the anti-plaque efficacy of prototype dentifrices via a 4-day brushing regiment
Overall Status Completed
Start Date 2007-10-01
Completion Date 2008-01-01
Primary Completion Date 2008-01-01
Phase Phase 3
Study Type Interventional
Primary Outcome
Measure Time Frame
Plaque Index 8 weeks
Enrollment 25
Condition
Intervention

Intervention Type: Drug

Intervention Name: Fluoride

Description: Brush twice daily

Arm Group Label: Fluoride Toothpaste

Intervention Type: Drug

Intervention Name: Triclosan/Fluoride toothpaste

Description: Brush twice daily

Arm Group Label: Total/Whitening

Intervention Type: Drug

Intervention Name: Fluoride

Description: Brush twice daily

Arm Group Label: antibacterial plant extract 1

Other Name: honokiol

Intervention Type: Drug

Intervention Name: Fluoride

Description: Brush twice daily

Arm Group Label: antibacterial plant extract 2

Intervention Type: Other

Intervention Name: antibacterial plant extract

Description: Brush twice daily

Arm Group Label: antibacterial plant extract 2

Other Name: Honokiol

Eligibility

Criteria:

Inclusion Criteria: - Male or female volunteers 18-65 years of age. - Good general health. - Must sign informed consent form. - Must discontinue oral hygiene on the mornings of each appointment and between sampling periods. - No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study. Exclusion Criteria: - Medical condition which requires pre-medication prior to dental procedures/visits. - Medical condition which precludes eating/drinking for 12 hrs. - History of allergy to common dentifrice ingredients. - Subjects unable or unwilling to sign the informed consent form. - Moderate or advanced periodontal disease. - Two or more decayed untreated dental sites at screening. - Other disease of the hard or soft oral tissues. - Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation). - Use of medications that can currently affect salivary flow. - Current use of antibiotics. - Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1. - Pregnant or nursing women. - Participation in any other clinical study within 30 days prior to enrollment into this study. - Use of tobacco products. - Subjects who must receive dental treatment during the study dates. - Current use of Antibiotics for any purpose. - Immune compromised individuals (HIV,AIDS, immuno suppressive drug therapy).

Gender:

All

Minimum Age:

18 Years

Maximum Age:

65 Years

Healthy Volunteers:

Accepts Healthy Volunteers
Overall Official
Last Name Role
Yanfang Ren, DDS Principal Investigator
Overall Contact Contact information is only displayed when the study is recruiting subjects.
Location
Facility: Eastman Dental Center - University of Rochester
Location Countries

United States
Verification Date

2009-09-01
Responsible Party

Name Title: William DeVizio/VP - Clinical Research

Organization: Colgate Palmolive

Has Expanded Access No
Condition Browse
Number Of Arms 4
Arm Group

Label: Fluoride Toothpaste

Type: Placebo Comparator

Description: fluoride control

Label: Total/Whitening

Type: Active Comparator

Description: positive control

Label: antibacterial plant extract 1

Type: Experimental

Description: Honokiol

Label: antibacterial plant extract 2

Type: Experimental

Description: magnolol

Study Design Info

Allocation: Randomized

Intervention Model: Crossover Assignment

Primary Purpose: Treatment

Masking: Double (Participant, Investigator)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Diseases

Clinical Trials on Fluoride

Medical Conditions

Sponsors and Collaborators

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations